BioLife Solutions/BLFS

$17.59

4.7%
-
1D1W1MYTD1YMAX

About BioLife Solutions

BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) and broader biopharma markets. Its expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage and distribution. Its biopreservation media products, HypoThermosol FRS and CryoStor Freeze Media, are formulated to mitigate preservation-induced, delayed-onset cell damage and death which result when cells and tissues are subjected to reduced temperatures. Its bioproduction tools portfolio includes human platelet lysates for cell expansion. It is a provider of biological and pharmaceutical storage and cold chain logistics. Its monitoring systems allow customers real time tracking of the storage temperatures of their materials throughout the logistics process. It operates about five storage facilities in the United States and one facility in the Netherlands.

Ticker

BLFS

Sector

Healthcare

Trading on

NASDAQ

Industry

Medical Equipment & Supplies

CEO

Roderick De Greef

Employees

409

Headquarters

Bothell, United States

BLFS Metrics

BasicAdvanced
$718.46M
Market cap
-
P/E ratio
-$1.52
EPS
1.71
Beta
-
Dividend rate
$718.46M
1.71278
$24.50
$8.92
370.23K
2.859
1.829
5.769
7.904
-30.52%
-15.4%
-18.93%
-17.12%
5.015
2.122
7.829
-11.43%
54.04%
43.89%

What the Analysts think about BLFS

Analyst Ratings

Majority rating from 9 analysts.
Buy

Price Targets

Average projection from 8 analysts.
31.5% upside
High $30.00
Low $20.00
$17.59
Current price
$23.13
Average price target

BLFS Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-40.67% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$32.7M
-1.8%
Net income
$-13.3M
-54.3%
Profit margin
-40.67%
-53.46%

BLFS Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 12.2%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.32
-$0.23
-$0.67
-$0.30
-
Expected
-$0.21
-$0.20
-$0.38
-$0.34
-$0.31
Surprise
51.35%
15%
78.67%
-12.2%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for BioLife Solutions stock?

BioLife Solutions (BLFS) has a market cap of $718.46M as of April 23, 2024.

What is the P/E ratio for BioLife Solutions stock?

The price to earnings (P/E) ratio for BioLife Solutions (BLFS) stock is 0 as of April 23, 2024.

Does BioLife Solutions stock pay dividends?

No, BioLife Solutions (BLFS) stock does not pay dividends to its shareholders as of April 23, 2024.

When is the next BioLife Solutions dividend payment date?

BioLife Solutions (BLFS) stock does not pay dividends to its shareholders.

What is the beta indicator for BioLife Solutions?

BioLife Solutions (BLFS) has a beta rating of 1.71. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the BioLife Solutions stock price target?

The target price for BioLife Solutions (BLFS) stock is $23.13, which is 31.5% above the current price of $17.59. This is an average based on projections from 8 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell BioLife Solutions stock

Buy or sell BioLife Solutions stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing